These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 33324413)

  • 1. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights.
    Hart PC; Rajab IM; Alebraheem M; Potempa LA
    Front Immunol; 2020; 11():595835. PubMed ID: 33324413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms.
    Potempa LA; Rajab IM; Olson ME; Hart PC
    Front Immunol; 2021; 12():744129. PubMed ID: 34552600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.
    Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU
    Front Immunol; 2018; 9():675. PubMed ID: 29713320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role?
    Køstner AH; Fuglestad AJ; Georgsen JB; Nielsen PS; Christensen KB; Zibrandtsen H; Parner ET; Rajab IM; Potempa LA; Steiniche T; Kersten C
    Front Immunol; 2023; 14():1170443. PubMed ID: 37006231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects.
    Olson ME; Hornick MG; Stefanski A; Albanna HR; Gjoni A; Hall GD; Hart PC; Rajab IM; Potempa LA
    Front Immunol; 2023; 14():1264383. PubMed ID: 37781355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and inflammation: conformational changes affect function.
    Wu Y; Potempa LA; El Kebir D; Filep JG
    Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression.
    Rajab IM; Hart PC; Potempa LA
    Front Immunol; 2020; 11():2126. PubMed ID: 33013897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein: how conformational changes influence inflammatory properties.
    Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K
    Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes.
    McFadyen JD; Kiefer J; Braig D; Loseff-Silver J; Potempa LA; Eisenhardt SU; Peter K
    Front Immunol; 2018; 9():1351. PubMed ID: 29946323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C-Reactive Protein at Sites of Inflammation and Infection.
    Sproston NR; Ashworth JJ
    Front Immunol; 2018; 9():754. PubMed ID: 29706967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities.
    Potempa LA; Qiu WQ; Stefanski A; Rajab IM
    Front Cardiovasc Med; 2022; 9():979461. PubMed ID: 36158829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification.
    Potempa LA; Yao ZY; Ji SR; Filep JG; Wu Y
    Biophys Rep; 2015; 1():18-33. PubMed ID: 26942216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation and bioactivity evaluation of C-reactive protein intermediate.
    Lv JM; Wang MY
    PLoS One; 2018; 13(5):e0198375. PubMed ID: 29851992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, immunothrombosis and venous thromboembolism.
    Dix C; Zeller J; Stevens H; Eisenhardt SU; Shing KSCT; Nero TL; Morton CJ; Parker MW; Peter K; McFadyen JD
    Front Immunol; 2022; 13():1002652. PubMed ID: 36177015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases.
    Zeller J; Bogner B; McFadyen JD; Kiefer J; Braig D; Pietersz G; Krippner G; Nero TL; Morton CJ; Shing KSCT; Parker MW; Peter K; Eisenhardt SU
    Pharmacol Ther; 2022 Jul; 235():108165. PubMed ID: 35247517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond.
    McFadyen JD; Zeller J; Potempa LA; Pietersz GA; Eisenhardt SU; Peter K
    Subcell Biochem; 2020; 94():499-520. PubMed ID: 32189313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.
    Zeller J; Cheung Tung Shing KS; Nero TL; McFadyen JD; Krippner G; Bogner B; Kreuzaler S; Kiefer J; Horner VK; Braig D; Danish H; Baratchi S; Fricke M; Wang X; Kather MG; Kammerer B; Woollard KJ; Sharma P; Morton CJ; Pietersz G; Parker MW; Peter K; Eisenhardt SU
    EMBO Mol Med; 2023 Jan; 15(1):e16236. PubMed ID: 36468184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
    Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
    BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.
    Ullah N; Wu Y
    Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.